Thank you again for submitting your work to Molecular Systems Biology. We have now heard back from the two referees who agreed to evaluate your study. As you will see below, the reviewers think that the presented findings seem interesting. They raise however a series of concerns, which we would ask you to address in a revision of the manuscript.
The reviewers' recommendations are rather clear and therefore I think that there is no need to repeat all the points listed below. One particularly important point raised by both reviewers refers to the need to provide further evidence supporting the causal relationship between the ECM and cell proliferation. Please let me know in case you would like to discuss further any of the issues raised by the reviewers.
--------------------------------------------------------REFEREE REPORTS
Reviewer #1: Summary This paper analyzes the role of fibroblasts and extracellular matrix in the development of homeostasis and the response to wounding in mammalian skin. Motivated by experiments in embryonic and neonatal mice that show an inverse correlation between fibroblast proliferation and extracellular matrix (ECM) density and that quiescent fibroblasts are more efficient at producing ECM than those that proliferate, the authors hypothesized that the ECM negatively regulates fibroblast proliferation and this regulation plays a key role in determining the structure of the dermis.
To elucidate this process, the authors develop several mathematical models that range from wellmixed (spatially homogeneous) models to 3D models of the dermis that account for spatiotemporal interactions of multiple cell types. The models suggest that the negative feedback hypothesis is sufficient to achieve dermal homeostasis. The models suggest that active cell migration is not needed for maturation of the dermis (developmental approach to homeostasis), but that active migration is an important component of wound healing. Live imaging in mice confirms these conclusions.
General remarks
How tissues reach their correct size with the right distribution and numbers of cells and how these tissues regenerate after perturbations are fundamental problems in Developmental Biology that are still not well understood. This is an interesting study that tackles these questions for the dermal layer of mammalian skin and introduces what appears to be a new idea-a negative feedback loop between ECM and fibroblasts-for control of the dermal structure. The idea that active motion of fibroblasts is not needed for maturation is also interesting. It is to be expected that active motion is needed to heal wounds, however. The paper should be of interest to Developmental Biologists in general and Skin Biologists in particular and to Systems Biologists who seek to understand problems in Development through theoretical and computational methodologies.
Major Points
The data presented convincingly show that there is a correlation between ECM deposition and fibroblast proliferation. The mathematical models and the data suggest that this feedback is sufficient to characterize the approach to homeostasis during both maturation and wound healing. However, is the relationship between proliferation and ECM really causal? Could the authors provide evidence that it is the ECM that induces the anti-proliferative effect and not another signaling factor (e.g., produced by the fibroblasts themselves or other cells in the dermis) that induces quiescence? The result of this could be the same as the proposed mechanism but would provide a different interpretation of the results that would be important to know. The 3D tissue model that the authors use is based on the Cellular Potts model developed originally by Granier-Glazier-Hogeweg and implemented in the CompuCell3D framework. This is an appropriate modeling choice but unfortunately there are insufficient details presented either in the main text or the supplementary material for this reviewer to judge the simulations. In particular, there are numerous assumptions and it would be important to know which assumptions are critical to the authors' conclusions.
Minor Points
There are a number of typos in the paper that need to be corrected. The authors need to go over the manuscript carefully and also make sure all the text is consistent with the figures. The manuscript by Rognoni et al. describes a combined experimental and modeling work that focuses on understanding the spatiotemporal dynamics of dermis maturation during normal development and wound healing. The main premise of the manuscript is that the interrelation between proliferation and extracellular marix (ECM) deposition underlies these processes. The authors propose a model where fibroblast cells can switch between proliferating fibroblast (PF) and quiescent fibroblast (QF) states. They propose that the quiescent cells secrete ECM that inhibits the proliferating state and enhances the quiescent state. Experimentally, it is shown that proliferation is inversely proportional to ECM deposition both during normal maturation and during wound healing. It is also shown that during normal maturation there is no cell migration, but during wound healing there is a significant fibroblast migration from areas next to the wound. The authors develop a mathematical model to describe the relation between proliferation, ECM and cell migration. They develop three types of models: (1) A non-spatial regulatory network model describing the feedback between PFs, QFs, and ECM. (2) A 1D reaction-diffusion type model that describes cellular dynamics of wound healing in a simplified 1D geometry. (3) A detailed cellular Potts model that describes both normal dermis maturation and wound healing process in 3D. Overall the manuscript is well written, and the results provide compelling experimental and theoretical insights into the organization of the Dermis. It also fits quite well the scope of the MSB journal. However, there are a few important points that need to be addressed before it is accepted. These include: Major comments: 1. One of the main conjectures in the manuscript is that the ECM inhibits the proliferating state (PF) by enhancing the transition from that state to the quiescent state. The evidence for this feedback relies on the correlation between the increase of ECM and the decrease in proliferation. However, that correlation does not necessarily imply causation. It is important to provide evidence that inhibition of ECM deposition increases proliferation. It could be that the decline of proliferation is controlled by some other cellular process upstream of the ECM deposition. 2. Furthermore, on the modeling side, the authors should compare a mathematical model with a feedback of the ECM on PF (K4) to a model without such a feedback (but with some upstream signal that controls both decay in proliferation and ECM deposition). Are there unique features that can be explained only by the feedback model? 3. The authors argue that no active migration is required for the maturation process. The evidence to support that is a 200min movie (movie EV2) showing only small movement. This seems to me too short a movie to make this point as the maturation process proceeds over many days. I therefore think that a longer movie is required to make this point. Alternatively, the authors should quantitate the effective cell diffusion in their current movies and show that is consistent with no significant migration. 4. The authors use both a simplified 1D model (Fig. 5 ) and a 3D cellular Potts model to show wound closure. However, these models are fundamentally different in their assumptions. The 1D model simply assumes that the cell can diffuse into the wound. This seems an oversimplified assumption, as it well known that cells perform directional migration in response to signal from the wound. In fact, the author show that very nicely in movie EV6. This type of directional movement is inconsistent with random diffusion assumed in that model. I think that it would be much more insightful to introduce into the 1D model directed random walk. 5. The detailed 3D model shows that with the right assumptions, the wound closure can be recapitulated. However, the details are unclear. Information on the assumptions made and the details of the model are not provided. There is a general reference to previous work but this is not enough. In particular, it is not clear which features are required and which are not. For example, the detailed simulation (Fig. 6A) includes both blood clot and infiltrating immune cells. Are these two types required for the model to work? If so, under what conditions? It also includes Epidermis proliferation in response to the wound healing. Is that also necessary? More generally, the model should provide insights into the essential processes sufficient for recapitulating the process and not only provide a nice movie that looks like the real behavior. It would be useful to perform some parameter sensitivity which would identify the essential parameters for the process. 6. As mentioned above, the authors should provide a more complete description of the 3D model and its parameters, as they have done for the 1D model. Minor point: 1. The authors use the acronym MCS in multiple figure to denote time but do not define it anywhere. Point-by-point reply to the reviewers Reviewer #1:
Major Points
The data presented convincingly show that there is a correlation between ECM deposition and fibroblast proliferation. The mathematical models and the data suggest that this feedback is sufficient to characterize the approach to homeostasis during both maturation and wound healing. However, is the relationship between proliferation and ECM really causal? Could the authors provide evidence that it is the ECM that induces the anti-proliferative effect and not another signaling factor (e.g., produced by the fibroblasts themselves or other cells in the dermis) that induces quiescence? The result of this could be the same as the proposed mechanism but would provide a different interpretation of the results that would be important to know.
We thank the reviewer for this important point, which was also raised by Reviewer 2. To obtain experimental evidence for a causal relationship between fibroblast proliferation and ECM deposition we have now included two new experimental approaches in a new figure (Fig.2) . First, we show that fibroblasts reversibly stop proliferating when encased in a collagen gel. Secondly, we show that when dermal ECM is subjected to collagenase digestion fibroblasts resume proliferation. In both models the transition of fibroblasts between quiescence and proliferation occurs independently of an immune cell infiltrate. The new in vitro experiments demonstrate the strong interdependence of fibroblast proliferation and ECM deposition and strongly support our feedback model. The 3D tissue model that the authors use is based on the Cellular Potts model developed originally by Granier-Glazier-Hogeweg and implemented in the CompuCell3D framework. This is an appropriate modeling choice but unfortunately there are insufficient details presented either in the main text or the supplementary material for this reviewer to judge the simulations. In particular, there are numerous assumptions and it would be important to know which assumptions are critical to the authors' conclusions.
We thank the reviewer for raising this point. We have now created a GitHub repository, where we have uploaded the 3D model (https://github.com/aopisco/DermisMaturation). Additionally the methods section has been expanded to provide the information that was lacking previously. Our work can now be easily reproduced and expanded, a critical feature for the systems biology/computational biology community.
Minor Points
There are a number of typos in the paper that need to be corrected. The authors need to go over the manuscript carefully and also make sure all the text is consistent with the figures.
We have now corrected these errors.
P6. Proliferative fibroblasts are "blue" in Fig EV3A. This is now stated in the text.
P7. Epidermal signal strength was assumed to decline with age. Why? The authors should provide a reference.
We This has now been corrected. Fig 1A caption . The references to the "left" and "right" panels are reversed.
This has now been corrected.
P21. Fig 2 caption. "GF" is not defined.
This information is now added to the figure legend. We have now changed this. We have moved the text outside of the figure.
Reviewer #2:
Major comments: 1. One of the main conjectures in the manuscript is that the ECM inhibits the proliferating state (PF) by enhancing the transition from that state to the quiescent state. The evidence for this feedback relies on the correlation between the increase of ECM and the decrease in proliferation. However, that correlation does not necessarily imply causation. It is important to provide evidence that inhibition of ECM deposition increases proliferation. It could be that the decline of proliferation is controlled by some other cellular process upstream of the ECM deposition.
We thank the reviewer for pointing this out, in common with Reviewer 1, who raised the same point. To obtain experimental evidence for a causal relationship between fibroblast proliferation and ECM deposition we have now included two new experimental approaches in a new figure (Fig.2) . First, we show that fibroblasts reversibly stop proliferating when encased in a collagen gel. Secondly, we show that when dermal ECM is subjected to collagenase digestion fibroblasts resume proliferation. In both models the transition of fibroblasts between quiescence and proliferation occurs independently of an immune cell infiltrate. The new in vitro experiments demonstrate the strong interdependence of fibroblast proliferation and ECM deposition and strongly support our feedback model.
2. Furthermore, on the modeling side, the authors should compare a mathematical model with a feedback of the ECM on PF (K4) to a model without such a feedback (but with some upstream signal that controls both decay in proliferation and ECM deposition). Are there unique features that can be explained only by the feedback model?
We thank the reviewer for this comment. We have revised the Supplementary File EV1 (now part of Methods) by adding a sentence following equation (6), showing that the non-existence of a negative feedback loop would imply a zero-steady state for PF, QF and ECM, in contradiction with the data.
3. The authors argue that no active migration is required for the maturation process. The evidence to support that is a 200min movie (movie EV2) showing only small movement. This seems to me too short a movie to make this point as the maturation process proceeds over many days. I therefore think that a longer movie is required to make this point. Alternatively, the authors should quantitate the effective cell diffusion in their current movies and show that is consistent with no significant migration.
We agree and have now extended the movie to 700 min. We have also included stills from the later time points (Figure 3G ).
4. The authors use both a simplified 1D model (Fig. 5 ) and a 3D cellular Potts model to show wound closure. However, these models are fundamentally different in their assumptions. The 1D model simply assumes that the cell can diffuse into the wound. This seems an oversimplified assumption, as it well known that cells perform directional migration in response to signal from the wound. In fact, the author show that very nicely in movie EV6. This type of directional movement is inconsistent with random diffusion assumed in that model. I think that it would be much more insightful to introduce into the 1D model directed random walk.
The motivation for using two different assumptions is that we wanted to show that with the simplest assumption, that is, diffusion, could macroscopically recapitulate the observed behaviour. Nevertheless, in the 3D tissue model, we wanted to describe the system more realistically and we can actually account for the directional migration that we observe by live imaging in wound healing.
5
. The detailed 3D model shows that with the right assumptions, the wound closure can be recapitulated. However, the details are unclear. Information on the assumptions made and the details of the model are not provided. There is a general reference to previous work but this is not enough. In particular, it is not clear which features are required and which are not. For example, the detailed simulation (Fig. 6A) More generally, the model should provide insights into the essential processes sufficient for recapitulating the process and not only provide a nice movie that looks like the real behavior. It would be useful to perform some parameter sensitivity which would identify the essential parameters for the process.
We have now revised our methods section to include in detail all the model assumptions and their relevance for the model. Moreover, the code is now available in GitHub: https://github.com/aopisco/DermisMaturation. The new experiments in Figure 2A , B establish that the switch between fibroblast proliferation and quiescence can occur in the absence of epidermis, immune cells and a blood clot.
6. As mentioned above, the authors should provide a more complete description of the 3D model and its parameters, as they have done for the 1D model. This is now provided in the method section.
Minor point: 1. The authors use the acronym MCS in multiple figure to denote time but do not define it anywhere.
We have now defined this in the text.
2nd Editorial Decision 10 th July 2018
Thank you for sending us your revised manuscript. We have now heard back from reviewer #2 who was asked to evaluate your study. As you will see below the reviewer is satisfied with the modifications made and thinks that the study is now suitable for publication.
We are offering a "model curation service" together with Prof. Jacky Snoep and the FAIRDOM team. In brief, the aim is to enhance reproducibility and add value to papers including mathematical models. Jacky Snoep's summary on the model (*Model Curation Report*) is pasted below. As you will see, there are some minor issues, which we would ask you to fix when you submit your revision.
-
The authors have addressed all the points raised in the first round in an adequate manner. I particularly like the new experiments in Fig.2 showing a causal relation between ECM deposition and proliferation. The description of the 3D model has also improved significantly. I there recommend accepting the manuscript **Model Curation Report**:
The authors sent me a Mathematica notebook with the models described in the MSB manuscript. I could reproduce the simulation plots in the manuscript, and the model description in the manuscript is in agreement with the notebook.
I have only minor comments for improvement of Figure 3: 1) The schema in Fig. 3a is not consistent with the ODEs. I would advice to show all the rates in the schema, i.e. also include k5, k6, k7. In addition I would make a distinction between conversion (e.g. PF to QF) and activation (e.g. ECM effect on k4). Now both types of reactions are shown as a solid arrow. I would suggest to use a dotted arrow for activation, simply to prevent confusion. Thus, show an additional solid line from PF to QF for k4, with a dotted arrow from ECM pointing at k4. Similarly, QF is not converted to ECM, but rather activates the synthesis, i.e. should be a dotted line.
2) If I am correct ECM in Fig. 3c is not a percentage, but a density, so it should not have units "(%)". We have changed Fig 3A accordingly . Fig. 3c is not a percentage, but a density, so it should not have units "(%)". We have changed the axis labelling accordingly. Do the data meet the assumptions of the tests (e.g., normal distribution)? Describe any methods used to assess it.
2) If I am correct ECM in
Is there an estimate of variation within each group of data?
Is the variance similar between the groups that are being statistically compared?
6. To show that antibodies were profiled for use in the system under study (assay and species), provide a citation, catalog number and/or clone number, supplementary information or reference to an antibody validation profile. e.g., Antibodypedia (see link list at top right), 1DegreeBio (see link list at top right). Any descriptions too long for the figure legend should be included in the methods section and/or with the source data.
In the pink boxes below, please ensure that the answers to the following questions are reported in the manuscript itself. Every question should be answered. If the question is not relevant to your research, please write NA (non applicable). We encourage you to include a specific subsection in the methods section for statistics, reagents, animal models and human subjects.
definitions of statistical methods and measures:
a description of the sample collection allowing the reader to understand whether the samples represent technical or biological replicates (including how many animals, litters, cultures, etc.).
Please fill out these boxes ê (Do not worry if you cannot see all your text once you press return) a specification of the experimental system investigated (eg cell line, species name).
C--Reagents

B--Statistics and general methods
the assay(s) and method(s) used to carry out the reported observations and measurements an explicit mention of the biological and chemical entity(ies) that are being measured. an explicit mention of the biological and chemical entity(ies) that are altered/varied/perturbed in a controlled manner.
Data
the data were obtained and processed according to the field's best practice and are presented to reflect the results of the experiments in an accurate and unbiased manner. figure panels include only data points, measurements or observations that can be compared to each other in a scientifically meaningful way. graphs include clearly labeled error bars for independent experiments and sample sizes. Unless justified, error bars should not be shown for technical replicates. if n< 5, the individual data points from each experiment should be plotted and any statistical test employed should be justified the exact sample size (n) for each experimental group/condition, given as a number, not a range;
Each figure caption should contain the following information, for each panel where they are relevant:
Captions
The data shown in figures should satisfy the following conditions:
Source Data should be included to report the data underlying graphs. Please follow the guidelines set out in the author ship guidelines on Data Presentation.
YOU MUST COMPLETE ALL CELLS WITH A PINK BACKGROUND ê
No specific method was used.
No statistical method was used to estimate sample size.
No samples were excluded from the analysis.
No
No specific randomization method was used. If not specified otherwise, male and females were used.
No specific blinding method was applied.
Yes
If a statistical test was applied, normal distribution was tested.
Yes Yes
Following antibodies were used: CD26 PercPcy5.5 (eBioscience, 45--0261), Ly--6A/E PE (eBioscience, Clone D7), CD45 APC (eBioscience, Clone), CD31 APC (eBioscience, Clone D7), CD234 APC (eBioscience, Clone D7), Dlk1 PE (MBL International, D187--5), Vimentin (Cell signalling, #5741), CD26 (R&D Systems, AF954), Sca1 (BD Pharmingen, clone E13--161.7), GFP (abcam, ab13970 and A--11122, ThermoFisher), Ki67 (abcam, ab16667 and Invitrogen, clone SolA15), α−sma (Abcam, ab5694), Krt14 (BioLegend, 906001) and CD49f (BioLegend, clone GoH3)
